Genome Diagnostics
GenDx (Genome Diagnostics B.V.) is a Netherlands-based molecular diagnostics company that develops NGS-based reagents, kits, and analysis software for HLA typing, chimerism monitoring, and immunogenetics, serving HLA laboratories, transplant centers, and pharmaceutical partners globally. It is a subsidiary of Eurobio Scientific Group.
- Company typePrivate
- Founded2005
- HeadquartersUtrecht, Netherlands
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Genome Diagnostics does
Genome Diagnostics B.V., operating as GenDx, is a Netherlands-based molecular diagnostics company founded in 2005 and headquartered in Utrecht, with a US subsidiary in San Diego. The company specializes in NGS-based reagents and analysis software for transplantation diagnostics, including high-resolution HLA typing, post-transplant chimerism monitoring, KIR genotyping, and MICA/MICB typing. Its core product portfolio comprises the NGSgo assay family (NGSgo-MX6-1, NGSgo-MX11-3, NGSgo-AmpX), the NGSengine analysis software, custom laboratory services, and companion diagnostics programs that integrate with pharmaceutical clinical trials. GenDx also operates the GenDx Academy, an online HLA learning platform launched in June 2026 for customer training and education.
GenDx sells to HLA laboratories, transplant centers, and pharmaceutical sponsors through a hybrid direct-sales and global distributor model, generating revenue from reagent and kit sales (hardware-style), software licensing (recurring), contract laboratory services, and companion diagnostics development. The product stack is supported by an unusually broad regulatory footprint — ISO 13485:2016, EU IVDR QMS with CE marking across seven product codes, MDSAP for Canada and Brazil, Korean GMP, and Health Canada Medical Device Licenses for both assays and software — which functions as a material barrier to entry in regulated transplant diagnostics markets.
The company is a specialized subsidiary of Eurobio Scientific Group, a diversified diagnostics conglomerate, and operates with a headcount in the 51-100 range. Its customer base includes large academic medical centers and national health systems (e.g., Atrium Wake Forest Baptist, University Health Network Toronto, NHS, Integrated BioBank of Luxembourg), and the company emphasizes world-class technical support, customer education through GenDx Academy, and continuous product development as core differentiators in a niche clinical market.
Genome Diagnostics firmographics
Firmographics- Name
- Genome Diagnostics
- Legal name
- Genome Diagnostics B.V.
- Website
- https://gendx.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- GenDx (Genome Diagnostics B.V.) is a Netherlands-based molecular diagnostics company that develops NGS-based reagents, kits, and analysis software for HLA typing, chimerism monitoring, and immunogenetics, serving HLA laboratories, transplant centers, and pharmaceutical partners globally. It is a subsidiary of Eurobio Scientific Group.
- Ownership category
- akta.pro rank
Genome Diagnostics industry classification
Industry- Product category
- Transplant Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Companion Diagnostic (CDx) Co-Development Services (biopharma partnerships, clinical strategy) (HLAAAMAB)
Keywords
Where Genome Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Utrecht
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
Genome Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Molecular Diagnostic Products: Sale of reagents, kits, and consumables for HLA typing, chimerism monitoring, and related immunogenetics testing performed in customer laboratories.
- Analysis Software Licenses: Licensing of software packages for data analysis, interpretation, and reporting of genetic testing results.
- Custom Laboratory Services: Contract laboratory services providing specialized testing capabilities for customers without in-house capacity.
- Companion Diagnostics: Co-development and provision of diagnostic tests alongside pharmaceutical partners for companion diagnostic applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free registration for product information access |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
Genome Diagnostics product offering
Product offeringCore offering
GenDx develops, manufactures, and sells NGS-based molecular diagnostic kits and reagents (NGSgo product line) for HLA typing, chimerism monitoring, KIR typing, and MICA/MICB typing used in transplantation workflows. The reagents are bundled with NGSengine, the company's proprietary analysis software, and complemented by Custom Lab Services for contract testing and Companion Diagnostics programs supporting clinical trials and personalized medicine.
Product overview
GenDx operates as a science-based molecular diagnostics company specializing in transplantation healthcare, offering an integrated portfolio of NGS-based laboratory reagents and companion software products. The core offering consists of HLA Typing products (including NGSgo-MX6-1, NGSgo-MX11-3, and NGSgo-AmpX kits), Chimerism Monitoring reagents, KIR Typing, and MICA/MICB Typing products—all paired with the proprietary NGSengine analysis software. Beyond reagents, GenDx provides Custom Lab Services for contract testing and Companion Diagnostics programs supporting clinical trials. The company recently launched GenDx Academy as an online educational platform complementing its product portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- GenDx Academy: Dedicated online HLA learning platform for GenDx customers offering product trainings, case studies, and educational resources.
Products and services
- NGS HLA Typing Products
Quantifiable outcome
- 87% of office-based employees commute by bicycle, walking, or public transport (sustainability metric)
Companies that use Genome Diagnostics
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Genome Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Genome Diagnostics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Eurobio Scientific GroupcoreEurobio Scientific Group is the parent company of GenDx, providing corporate ownership and strategic resources while allowing GenDx to operate as a specialized subsidiary focused on transplant diagnostics.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Genome Diagnostics competitors and assessment
Company assessmentDirect peers
- CareDx: CareDx is a transplant-focused diagnostics company offering testing services and products across pre- and post-transplant care. It overlaps with GenDx in transplant-related molecular diagnostics and chimerism monitoring.
- Immucor: Immucor provides transfusion and transplantation diagnostics, including HLA typing reagents and instruments. It competes with GenDx in HLA-related immunogenetics products for transplant and immunohematology labs.
- One Lambda (Thermo Fisher Scientific): One Lambda, now part of Thermo Fisher Scientific, is the market-leading provider of HLA typing reagents and software for transplantation. It is the most direct competitor to GenDx in NGS-based HLA typing and transplant immunogenetics.
- Linkage Biosciences: Linkage Biosciences offers HLA typing and chimerism monitoring products based on real-time PCR and NGS. It competes with GenDx's NGS chimerism monitoring and HLA typing reagent portfolio.
- Inno-Train Diagnostik: Inno-Train Diagnostik develops HLA typing and chimerism reagents using SSO and NGS methodologies. It is a comparable niche competitor to GenDx in transplant immunogenetics reagents.
- Histogenetics: Histogenetics is a specialized HLA typing laboratory services provider using NGS for high-resolution typing. It competes with GenDx's NGS HLA typing reagents and custom lab services for transplant matching workflows.
- Omixon: Omixon develops NGS-based HLA typing kits and software for transplantation diagnostics. It directly competes with GenDx in NGS HLA reagents and analysis software for clinical and research HLA labs.
- BAG Health Care (BAG Diagnostics): BAG Health Care provides molecular diagnostics for HLA typing and transplant immunology. It competes with GenDx in supplying HLA reagents and related typing solutions to transplant laboratories.
Emerging players
- TBG Diagnostics: TBG Diagnostics offers molecular diagnostics products including HLA typing services. It is a smaller player with partial overlap to GenDx's HLA typing portfolio, primarily in the Asia-Pacific region.
- Protrans: Protrans provides HLA typing reagents and cell therapy products for transplantation diagnostics. It has meaningful overlap with GenDx's HLA reagent portfolio in the European market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Genome Diagnostics social profiles
Digital presenceGenome Diagnostics compliance and trust
Trust signalCompliance6 records
Genome Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genome Diagnostics leadership team
Management profileNumber of profiles
Profiles2 records
Genome Diagnostics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genome Diagnostics M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genome Diagnostics
What does Genome Diagnostics do?
GenDx develops, manufactures, and sells NGS-based molecular diagnostic kits and reagents (NGSgo product line) for HLA typing, chimerism monitoring, KIR typing, and MICA/MICB typing used in transplantation workflows. The reagents are bundled with NGSengine, the company's proprietary analysis software, and complemented by Custom Lab Services for contract testing and Companion Diagnostics programs supporting clinical trials and personalized medicine.
Is Genome Diagnostics a public or private company?
Genome Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Genome Diagnostics founded?
Genome Diagnostics was founded in 2005. It employs 51 to 100 people.
Where is Genome Diagnostics based?
Genome Diagnostics is headquartered in Utrecht, Netherlands, in the Europe region.
How does Genome Diagnostics make money?
Four revenue lines are on record. Molecular Diagnostic Products are the primary driver. The others are analysis Software Licenses, custom Laboratory Services and companion Diagnostics.
Who are Genome Diagnostics's main competitors?
Direct peers on record are CareDx, Immucor, One Lambda (Thermo Fisher Scientific), Linkage Biosciences, Inno-Train Diagnostik, Histogenetics, Omixon and BAG Health Care (BAG Diagnostics). Emerging players are TBG Diagnostics and Protrans.
Does Genome Diagnostics have an API?
No public API is recorded for Genome Diagnostics.
What industry is Genome Diagnostics in?
Genome Diagnostics's product category is Transplant Diagnostics. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support). Its NAICS code is 325413 and its SIC code is 2835.